Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | -0.43% | 93.65 | 2.3% | $1015.98m | |
| MRK | Merck & Co., Inc. | -0.22% | 82.47 | 0.7% | $998.22m | |
| JNJ | Johnson & Johnson | -0.67% | 149.13 | 0.7% | $986.09m | |
| PFE | Pfizer Inc. | -0.55% | 36.31 | 0.9% | $935.39m | |
| BMY | Bristol-Myers Squibb Co. | -0.45% | 66.08 | 1.0% | $855.55m | |
| LLY | Eli Lilly & Co. | -0.10% | 140.98 | 1.1% | $484.80m | |
| NVS | Novartis AG | -0.43% | 97.21 | 0.2% | $212.23m | |
| GSK | GlaxoSmithKline Plc | -0.43% | 43.55 | 0.2% | $168.29m | |
| AZN | AstraZeneca Plc | 2.76% | 49.17 | 1.2% | $142.61m | |
| RETA | Reata Pharmaceuticals, Inc. | 1.10% | 228.14 | 3.5% | $96.68m | |
| NVO | Novo Nordisk A/S | 1.02% | 64.10 | 0.1% | $83.39m | |
| GNPX | Genprex, Inc. | 14.49% | 4.90 | 0.0% | $82.51m | |
| SNY | Sanofi | 2.42% | 51.14 | 0.2% | $82.48m | |
| BHC | Bausch Health Cos., Inc. | 1.21% | 28.08 | 0.0% | $80.83m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 2.41% | 46.42 | 0.0% | $61.69m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.